Immediate, Actionable, Affordable
Chipcare is developing a highly versatile, multiplexed point-of-care in-vitro diagnostic platform to enable healthcare professionals to rapidly and accurately perform lab quality tests using easily collected samples to aid in the differential diagnosis and monitoring of a wide range of infectious diseases.
Chipcare’s initial focus is on Sexually Transmitted Infections (STIs) and Antimicrobial Resistance in North America and Europe, enabling Healthcare Professionals to diagnose and prescribe the right treatment in a single visit, significantly enhancing the overall quality of patient care.
Chipcare is a Toronto-based biotechnology company developing a highly versatile point-of-care (POC) diagnostic platform which will enable unparalleled sample-to-action workflow in the clinic.
Get to know us better
ChipCare currently employs 30+ people in downtown Toronto. The team brings together multiple engineering disciplines and assay development scientists with experience in product development and commercialization.
ChipCare is registered to ISO 13485:2016 and maintains a licensed containment level 2 laboratory.
Copyright © 2021. All rights reserved.